Cas:260430-93-1 6-fluoroquinoline-2-carbaldehyde manufacturer & supplier

Chemical Name:6-fluoroquinoline-2-carbaldehyde

CAS.NO:260430-93-1

Synonyms:6-Fluoroquinoline-2-carbaldehyde;6-fluoro-2-quinolinecarbaldehyde;6-Fluoro-quinoline-2-carbaldehyde

Molecular Formula:C₁₀H₆FNO

Molecular Weight:175.15900

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:29.96000

Exact Mass:175.04300

LogP:2.18640

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like 6-Fluoroquinoline-2-carbaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-Fluoro-quinoline-2-carbaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-Fluoroquinoline-2-carbaldehyde Use and application,6-Fluoroquinoline-2-carbaldehyde technical grade,usp/ep/jp grade.

Related News: AXON is planning a follow-up trial that will include a better-defined group of Alzheimer’s patients suffering from both amyloid plaques and tau tangles, Novak said. 6-fluoroquinoline-2-carbaldehyde manufacturer The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented. 6-fluoroquinoline-2-carbaldehyde supplier Dr. John K. Westwick, CEO of Resonant, added ��Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates. 6-fluoroquinoline-2-carbaldehyde vendor The use of contrast agents is different from other drugs, and it needs to be used with corresponding equipment. In recent years, China is in the growth period of imaging equipment. 6-fluoroquinoline-2-carbaldehyde factory The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.